Cancer Research and Treatment

Cancer Research and Treatment Search

> Browse Articles > Search

General

A Multicenter, Prospective, Observational Study to Evaluate Ethanol-Induced Symptoms in Patients Receiving Docetaxel Chemotherapy

Young-Woong Won, Jin-Hyoung Kang, Jung Hye Kwon, Dong-Hoe Koo, Jung Hun Kang, Chi Hoon Maeng, Hee Kyung Ahn, Sung Yong Oh, Dae-Won Lee, Joohyuk Sohn, So Yeon Oh, Kyung Hee Lee, Su-Jin Koh, Keun Seok Lee, Chan-Kyu Kim, Ji-Yeon Kim, Jun Ho Ji, Sung-Bae Kim, Joo Young Ha, Ho Young Kim

Cancer Res Treat. 2023;55(4):1096-1103. Published online April 7, 2023 DOI: https://doi.org/10.4143/crt.2022.1565

Breast cancer

Real-World Evidence of Trastuzumab, Pertuzumab, and Docetaxel Combination as a First-Line Treatment for Korean Patients with HER2-Positive Metastatic Breast Cancer

Yong-Pyo Lee, Min-Sang Lee, HongSik Kim, Ji-Yeon Kim, Jin Seok Ahn, Young-Hyuck Im, Yeon Hee Park

Cancer Res Treat. 2022;54(4):1130-1137. Published online January 17, 2022 DOI: https://doi.org/10.4143/crt.2021.1103

Web of Science 2 Crossref 3

Head and Neck cancer

A Single-Arm, Prospective, Phase II Study of Cisplatin Plus Weekly Docetaxel as First-Line Therapy in Patients with Metastatic or Recurrent Salivary Gland Cancer

Hye Ryeon Kim, Su Jin Lee, Sehhoon Park, Hyun Ae Jung, Se-Hoon Lee, Han-Sin Jeong, Man Ki Chung, Myung-Ju Ahn

Cancer Res Treat. 2022;54(3):719-727. Published online November 1, 2021 DOI: https://doi.org/10.4143/crt.2021.1019

Web of Science 6 Crossref 4

Breast cancer

Potentiation of the Anticancer Effects by Combining Docetaxel with Ku-0063794 against Triple-Negative Breast Cancer Cells

Ye-Won Jeon, Ok-Hee Kim, Jin Sun Shin, Ha Eun Hong, Cho Hee Kim, Say-June Kim

Cancer Res Treat. 2022;54(1):157-173. Published online April 5, 2021 DOI: https://doi.org/10.4143/crt.2020.1063

Web of Science 3 Crossref 4

Prediction of Acquired Taxane Resistance Using a Personalized Pathway-Based Machine Learning Method

Young Rae Kim, Dongha Kim, Sung Young Kim

Cancer Res Treat. 2019;51(2):672-684. Published online August 10, 2018 DOI: https://doi.org/10.4143/crt.2018.137

Web of Science 6 Crossref 6

S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial

Choong-kun Lee, Minkyu Jung, Hyo Song Kim, Inkyung Jung, Dong Bok Shin, Seok Yun Kang, Dae Young Zang, Ki Hyang Kim, Moon Hee Lee, Bong-Seog Kim, Kyung Hee Lee, Jae-Ho Cheong, Woo Jin Hyung, Sung Hoon Noh, Hyun Cheol Chung, Sun Young Rha

Cancer Res Treat. 2019;51(1):1-11. Published online February 5, 2018 DOI: https://doi.org/10.4143/crt.2018.028

Web of Science 21 Crossref 11

Gemcitabine and Docetaxel Combination for Advanced Soft Tissue Sarcoma: A Nationwide Retrospective Study

Yunjung Choi, Mi Sun Yun, Sang Hee Lim, Jeeyun Lee, Jin-Hee Ahn, Yu Jung Kim, Kyong Hwa Park, Young Suk Park, Ho Yeong Lim, Hyonggin An, Dong-Churl Suh, Yeul Hong Kim

Cancer Res Treat. 2018;50(1):175-182. Published online March 30, 2017 DOI: https://doi.org/10.4143/crt.2016.535

Web of Science 15 Crossref 18

A Multicenter Randomized Phase II Study of Docetaxel vs. Docetaxel Plus Cisplatin vs. Docetaxel Plus S-1 as Second-Line Chemotherapy in Metastatic Gastric Cancer Patients Who Had Progressed after Cisplatin Plus Either S-1 or Capecitabine

Keun-Wook Lee, Bum Jun Kim, Mi-Jung Kim, Hye Sook Han, Jin Won Kim, Young Iee Park, Sook Ryun Park

Cancer Res Treat. 2017;49(3):706-716. Published online October 18, 2016 DOI: https://doi.org/10.4143/crt.2016.216

Web of Science 12 Crossref 12

East Asian Subgroup Analysis of a Randomized, Double-Blind, Phase 3 Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-small Cell Lung Cancer Following Disease Progression after One Prior Platinum-Based Therapy (REVEL)

Keunchil Park, Joo-Hang Kim, Eun Kyung Cho, Jin-Hyoung Kang, Jin-Yuan Shih, Annamaria Hayden Zimmermann, Pablo Lee, Ekaterine Alexandris, Tarun Puri, Mauro Orlando

Cancer Res Treat. 2016;48(4):1177-1186. Published online February 22, 2016 DOI: https://doi.org/10.4143/crt.2015.401

Web of Science 16 Crossref 14

Caveolin-1 Modulates Docetaxel-Induced Cell Death in Breast Cancer Cell Subtypes through Different Mechanisms

Jinho Kang, Joo Hee Park, Hye Jin Lee, Ukhyun Jo, Jong Kuk Park, Jae Hong Seo, Yeul Hong Kim, Insun Kim, Kyong Hwa Park

Cancer Res Treat. 2016;48(2):715-726. Published online September 21, 2015 DOI: https://doi.org/10.4143/crt.2015.227

Web of Science 21 Crossref 18

Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine

Choong-kun Lee, Minkyu Jung, Hye Jin Choi, Hye Ryun Kim, Hyo Song Kim, Mi Ryung Roh, Joong Bae Ahn, Hyun Cheol Chung, Su Jin Heo, Sun Young Rha, Sang Joon Shin

Cancer Res Treat. 2015;47(4):781-789. Published online February 16, 2015 DOI: https://doi.org/10.4143/crt.2014.261

Web of Science 7 Crossref 8

Genetic Variations of Drug Transporters Can Influence on Drug Response in Patients Treated with Docetaxel Chemotherapy

Jung Ran Choi, Jeong-Oh Kim, Dae Ryong Kang, Jung-Young Shin, Xiang Hua Zhang, Ji Eun Oh, Ji-Young Park, Kyoung-Ah Kim, Jin-Hyoung Kang

Cancer Res Treat. 2015;47(3):509-517. Published online December 16, 2014 DOI: https://doi.org/10.4143/crt.2014.012

Web of Science 33 Crossref 29

Outcomes of Third-Line Docetaxel-Based Chemotherapy in Advanced Gastric Cancer Who Failed Previous Oxaliplatin-Based and Irinotecan-Based Chemotherapies

Min Jeong Lee, In Gyu Hwang, Joung-Soon Jang, Jin Hwa Choi, Byeong-Bae Park, Myung Hee Chang, Seung Tae Kim, Se Hoon Park, Myoung Hee Kang, Jung Hun Kang

Cancer Res Treat. 2012;44(4):235-241. Published online December 31, 2012 DOI: https://doi.org/10.4143/crt.2012.44.4.235

Crossref 22

Weekly Gemcitabine and Docetaxel in Refractory Soft Tissue Sarcoma: A Retrospective Analysis

Ha-young Lee, Sang Joon Shin, Hyo Song Kim, Soo Jung Hong, Jung Woo Han, Seung Taek Lim, Jae Kyung Roh, Sun Young Rha

Cancer Res Treat. 2012;44(1):43-49. Published online March 31, 2012 DOI: https://doi.org/10.4143/crt.2012.44.1.43

Crossref 13

Phase II Study of S-1 Plus Either Irinotecan or Docetaxel for Non-small Cell Lung Cancer Patients Treated with More Than Three Lines of Treatment

Dal Yong Kim, Dae Ho Lee, Sun-Joo Jang, Sang-We Kim, Cheolwon Suh, Jung Shin Lee

Cancer Res Treat. 2011;43(4):212-216. Published online December 27, 2011 DOI: https://doi.org/10.4143/crt.2011.43.4.212

Crossref 1

Efficacy and Safety of Docetaxel Plus Prednisolone Chemotherapy for Metastatic Hormone-Refractory Prostate Adenocarcinoma: Single Institutional Study in Korea

Jae-Lyun Lee, Jeong Eun Kim, Jin-Hee Ahn, Dae-Ho Lee, Jungshin Lee, Choung-Soo Kim, Jun Hyuk Hong, Bumsik Hong, Cheryn Song, Hanjong Ahn

Cancer Res Treat. 2010;42(1):12-17. Published online March 31, 2010 DOI: https://doi.org/10.4143/crt.2010.42.1.12

Crossref 18

Docetaxel versus Paclitaxel Combined with 5-FU and Leucovorin in Advanced Gastric Cancer: Combined Analysis of Two Phase II Trials

Hong Jae Chon, Sun Young Rha, Chong Kun Im, Chan Kim, Min Hee Hong, Hye Ryun Kim, Jung Ryun An, Sung Hoon Noh, Hyun Cheol Chung, Hei-Cheul Jeung

Cancer Res Treat. 2009;41(4):196-204. Published online December 31, 2009 DOI: https://doi.org/10.4143/crt.2009.41.4.196

Crossref 22

A Phase II Study of Leucovorin, 5-FU and Docetaxel Combination Chemotherapy in Patients with Inoperable or Postoperative Relapsed Gastric Cancer

Kwang-Sun Lee, Ha-Yeon Lee, Eun-Kyung Park, Joung-Soon Jang, Sang-Jae Lee

Cancer Res Treat. 2008;40(1):11-15. Published online March 31, 2008 DOI: https://doi.org/10.4143/crt.2008.40.1.11

Crossref 2

The Efficacy of an Induction Chemotherapy Combination with Docetaxel, Cisplatin, and 5-FU Followed by Concurrent Chemoradiotherapy in Advanced Head and Neck Cancer

Jae-Sook Ahn, Sang-Hee Cho, Ok-Ki Kim, Joon-Kyoo Lee, Deok-Hwan Yang, Yeo-Kyeoung Kim, Je-Jung Lee, Sang-Chul Lim, Hyeoung-Joon Kim, Woong-Ki Chung, Ik-Joo Chung

Cancer Res Treat. 2007;39(3):93-98. Published online September 30, 2007 DOI: https://doi.org/10.4143/crt.2007.39.3.93

Crossref 17

Phase II Study of Docetaxel and Cisplatin as First-line Chemotherapy in Patients with Recurrent or Metastatic Gastric Cance

Kyung-Ha Kim, Ki-Ju Jeung, Hyun-Jung Kim, Sang-Byung Bae, Chan-Kyu Kim, Nam-Su Lee, Kyu-Taek Lee, Sung-Kyu Park, Jong-Ho Won, Dae-Sik Hong, Hee-Sook Park

Cancer Res Treat. 2007;39(2):49-53. Published online June 30, 2007 DOI: https://doi.org/10.4143/crt.2007.39.2.49

Crossref 4

Induction Chemotherapy of Docetaxel and Cisplatin for the Elderly Patients with Squamous Cell Carcinoma of the Head and Neck

Young-Jin Choi, Jooseop Chung, Ho-Jin Shin, Goon-Jae Cho, Soo-Geun Wang, Byung-Joo Lee, Byung-Mann Cho, Dong-Won Kim, Hak-Jin Kim, Won Sik Lee, Young-Don Joo, Chang-Hak Sohn

Cancer Res Treat. 2007;39(1):1-5. Published online March 31, 2007 DOI: https://doi.org/10.4143/crt.2007.39.1.1

Crossref 8

The Safety and Efficacy of Second-line Single Docetaxel (75 mg/m²) Therapy in Advanced Non-Small Cell Lung Cancer Patients who were Previously Treated with Platinum-based Chemotherapy

Byoung Yong Shim, Chi Hong Kim, So Hyang Song, Meyung Im Ahn, Eun Jung Hong, Sung Whan Kim, Suzy Kim, Min Seop Jo, Deog Gon Cho, Kyu Do Cho, Jinyoung Yoo, Hoon-Kyo Kim

Cancer Res Treat. 2005;37(6):339-343. Published online December 31, 2005 DOI: https://doi.org/10.4143/crt.2005.37.6.339

Crossref 5

Randomized, Multi-center Phase II Trial of Docetaxel Plus Cisplatin Versus Etoposide Plus Cisplatin as the First-line Therapy for Patients with Advanced Non-Small Cell Lung Cancer

Nam-Su Lee, Hee-Sook Park, Jong-Ho Won, Dae-Sik Hong, Su-Taek Uh, Sang-Jae Lee, Joo-Hang Kim, Se-Kyu Kim, Myung-Ju Ahn, Jung-Hye Choi, Suk-Chul Yang, Jung-Ae Lee, Keun-Seok Lee, Chang-Yeol Yim, Yong-Chul Lee, Chul-Soo Kim, Moon-Hee Lee, Kab-Do Jung, Hanlim Moon, Yl-Sub Lee

Cancer Res Treat. 2005;37(6):332-338. Published online December 31, 2005 DOI: https://doi.org/10.4143/crt.2005.37.6.332

Crossref 1

Efficacy and Safety Study of Docetaxel as Salvage Chemotherapy in Metastatic Gastric Cancer Failing Fluoropyrimidine and Platinum Combination Chemotherapy

Jae-Lyun Lee, Min-Hee Ryu, Heung Moon Chang, Tae-Won Kim, Jeong Hwan Yook, Sung Tae Oh, Byung Sik Kim, Jung Shin Lee, Yoon-Koo Kang

Cancer Res Treat. 2005;37(4):201-207. Published online August 31, 2005 DOI: https://doi.org/10.4143/crt.2005.37.4.201

Crossref 4

The Efficacy of Docetaxel and Cisplatin Combination Chemotherapy for the Treatment of Advanced Gastric Cancer after Failing to 5-Fluorouracil Based Chemotherapy

Sang-Joon Shin, Min-Kyoung Kim, Kyung-Hee Lee, Myung-Soo Hyun, Sang Woon Kim, Sun Kyo Song, Sung-Hwa Bae, Hun-Mo Ryoo

Cancer Res Treat. 2004;36(6):367-371. Published online December 31, 2004 DOI: https://doi.org/10.4143/crt.2004.36.6.367

Crossref 5

A Phase II Trial of Docetaxel and Ifosfamide for Patients with Platinum-Resistant or Refractory Non-Small Cell Lung Cancer in a Salvage Setting

Gyeong-Won Lee, Jung-Hun Kang, Seok-Hyun Kim, Hea Yong Lee, Ho-Cheol Kim, Won-Sup Lee, Jong-Duk Lee, Young-Sil Hwang, Joung-Soon Jang, Jong-Seok Lee

Cancer Res Treat. 2004;36(5):287-292. Published online October 31, 2004 DOI: https://doi.org/10.4143/crt.2004.36.5.287

Crossref 1

Effect of Combination Chemotherapy with Docetaxel Plus Cisplatin in Patients with Advanced Non-Small Cell Lung Cancer

Hee Jung Kang, Min Kyoung Kim, Young Gil Kim, Jae Lyun Lee, Kyung Hee Lee, Myung Soo Hyun, Sung Hwa Bae, Hun Mo Ryoo

Cancer Res Treat. 2003;35(4):299-303. Published online August 31, 2003 DOI: https://doi.org/10.4143/crt.2003.35.4.299

Docetaxel and Cisplatin Combination Chemotherapy in Patients with Squamous Cell Carcinomas of the Head and Neck

Jung Hyun Lee, Kyung Woo Lee, Young Jin Choi, Jae Hoon Choi, Ho Jin Shin, Joo Seop Chung, Goon Jae Cho, Byung Ju Lee, Soo Geun Wang

Cancer Res Treat. 2003;35(3):261-266. Published online June 30, 2003 DOI: https://doi.org/10.4143/crt.2003.35.3.261

Crossref 2

Infusional 5-Fluorouracil, Leucovorin and Docetaxel in Advanced Gastric Cancer

Yong Tai Kim, Joo Hyuk Sohn, So Hun Kim, Sun Young Rha, Chul Kim, Jae Kyung Roh, Byung Soo Kim, Woo Ick Jang, Hyun Cheol Chung

Cancer Res Treat. 2003;35(2):123-129. Published online April 30, 2003 DOI: https://doi.org/10.4143/crt.2003.35.2.123

Crossref 1

The Efficacy and Safety of Docetaxel in Patients with Anthracychne pretreated Metastatic Breast Cancer: A Multicenter Phase II Study

Joong Bae Ahn, Kwang Yong Shim, Joon Oh Park, Hei Chul Jung, Nae Choon Yoo, Hyun Cheol Chung, Joo Hang Kim, Jin Hyuk Choi, Hyun Soo Kim, Hugh Chul Kim, Woo Kun Kim, Jae Kyung Roh

J Korean Cancer Assoc. 2000;32(2):235-243.